GET THE COMPLETE DIAGNOSTIC PICTURE
GET THE COMPLETE DIAGNOSTIC PICTURE
Karius is a life sciences company focused on saving lives. We are committed to advancing diagnostic science and technology to optimize treatment for infectious disease.
The Karius Test® is a liquid biopsy for infectious diseases. From a single blood sample, the Karius Test can non-invasively and rapidly detect over 1,000 pathogens associated with both deep-seated and bloodstream infections. The Karius Test may help clinicians avoid many invasive, low-yield, and sequential diagnostic tests that can delay treatment for vulnerable hospitalized patients.
We use genomics and AI to advance infectious disease diagnostics.
Microbial Cell-Free DNA
Karius provides unique genomic insights by detecting microbial cell–free DNA (mcfDNA) circulating in the bloodstream from more than 1000 pathogens that cause infections.
AI Technology
Advanced machine learning algorithms allow analysis of complex genomic data in real time. Our proprietary reference genome databases are constantly refined as more data becomes available.
A Novel Liquid Biopsy
Infections are one of the leading causes of morbidity and mortality in immunocompromised patients. See how the Karius Test can provide clinicians with clear diagnostic insight.
